✦ LIBER ✦

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

✍ Scribed by Hans-Christoph Diener; Stuart J Connolly; Michael D Ezekowitz; Lars Wallentin; Paul A Reilly; Sean Yang; Denis Xavier; Giuseppe Di Pasquale; Salim Yusuf

Book ID: 114409664
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 177 KB
Volume: 9
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70274-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apixaban compared with warfarin in patie

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

✍ J Donald Easton; Renato D Lopes; M Cecilia Bahit; Daniel M Wojdyla; Christopher 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 264 KB

Rivaroxaban compared with warfarin in pa

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

✍ Graeme J Hankey; Manesh R Patel; Susanna R Stevens; Richard C Becker; Günter Bre 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 252 KB

DABIGATRAN ETEXILATE VERSUS WARFARIN IN

DABIGATRAN ETEXILATE VERSUS WARFARIN IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATION: A RE-LY® SUBGROUP ANALYSIS

✍ Greg C. Flaker; Paul Reilly; Salim Yusuf; Mike Ezekowitz; Lars Wallentin; Martin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Apixaban versus aspirin in patients with

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

✍ Hans-Christoph Diener; John Eikelboom; Stuart J Connolly; Campbell D Joyner; Rob 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 208 KB

DABIGATRAN VERSUS WARFARIN IN ATRIAL FIB

DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH LOW, MODERATE AND HIGH CHADS2 SCORE: A RE-LY SUBGROUP ANALYSIS

✍ Jonas Oldgren; Marco Alings; Harald Darius; John Eikelboom; Michael Ezekowitz; A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and safety of dabigatran compar

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

✍ Lars Wallentin; Salim Yusuf; Michael D Ezekowitz; Marco Alings; Marcus Flather; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 287 KB